How long does it take to feel Wegovy working?

Week one: your pen is in the fridge, but is anything actually happening?

You have done your first injection. The dose is 0.25mg. You check in with yourself the next morning and honestly cannot tell whether anything is different. That is entirely normal. The opening weeks of Wegovy are not about dramatic appetite suppression, they are about your system getting used to semaglutide at the gentlest possible level. GLP-1 medicines slow gastric emptying and act on appetite-regulating centres in the brain, but those effects scale with dose. At 0.25mg, the signal is quiet by design.

Some people do notice a subtle shift even at this stage, a slightly smaller portion feels enough, or a mid-afternoon snack urge simply does not arrive. Others feel nothing noticeably different for the whole first month. Both experiences sit within the normal range. Side effects, if they appear at all, are more likely to be felt before results are: nausea, tiredness, or some digestive unsettledness are the body's early response and usually settle within a few days. The NHS semaglutide page covers what to expect and when to contact a clinician.

Weeks four to twelve: the titration period, where things start to shift

The standard titration moves through 0.25mg, 0.5mg, 1.0mg and 1.7mg before reaching the 2.4mg maintenance dose, each step roughly four weeks apart, reviewed by a prescriber. The appetite-suppressing effect generally becomes more noticeable as the dose rises. By weeks four to eight, people are more commonly reporting that meals feel satisfying with less food, that hunger between meals is quieter, and that cravings for high-calorie foods are less insistent.

Weight on the scales may start moving in this window, though the rate varies considerably. A reduction of two to four pounds in the first month is a realistic early marker for many, not a guarantee. The body is also adjusting to less caloric intake, so energy levels can fluctuate. Keeping protein intake up and staying well hydrated matters during this period; it is worth raising any specific dietary questions with your prescriber or a dietitian. For a broader look at how semaglutide works for weight management, our Wegovy overview covers the mechanism and eligibility in detail.

Three months to six months: the window most people see meaningful progress

The clearest evidence for what Wegovy does over time comes from the STEP 1 trial, which followed adults with obesity over 68 weeks at the 2.4mg dose and reported an average weight reduction of around 15%, published in the New England Journal of Medicine. That figure is an average across a large group; some participants lost considerably more, others less. The trajectory is gradual and tends to steepen once the maintenance dose is reached.

By three months, most people who respond well to treatment will have lost a noticeable amount of weight, often five to ten percent of starting body weight or more. By six months, the picture is clearer still. NICE guidance notes that if less than five percent of body weight has been lost after six months at the highest tolerated dose, the prescriber should review whether continuing makes sense. That review point is useful to know about: it sets a real clinical benchmark rather than leaving people guessing indefinitely. If you are thinking about what treatment might cost over this period, our weight loss treatment overview sets out what is included.

Why some people feel it sooner, and what can slow things down

Starting weight, metabolic rate, how closely the lifestyle guidance is followed, and individual variation in GLP-1 receptor sensitivity all influence how long it takes to feel the effects of Wegovy. People with a higher starting BMI sometimes see larger absolute weight losses but a similar percentage reduction. Those who start Wegovy while also adjusting their diet and increasing activity tend to see earlier movement on the scales than those relying on the medicine alone.

Slower progress is not always a sign the medicine is not working. Dose titration takes time, and the body's response to a GLP-1 medicine builds over months. A question our prescribers hear regularly is whether to push the dose faster, but the titration schedule exists to protect against the nausea and digestive side effects that come with too rapid an increase. Patience in the early months pays off in tolerability later. If you have questions about your own experience or want to understand how quickly you can expect to feel Wegovy working, our page on that covers the early signs in detail. For those still weighing up whether to start, it is also worth reading about how long before the effects of Wegovy typically begin, and our separate guide on how long until you feel the effects of Wegovy walks through what the titration period means in practice. If you have questions about your own experience or want to understand the process before starting, a closer look at the week-by-week timeline may help, and our team is available through our contact page seven days a week. When you are ready to find out whether Wegovy is clinically suitable for you, check your eligibility with a free consultation at nume.